BSJ-01-175 | m-entrepreneurship.com

Product Name :
BSJ-01-175

Search keywords :
BSJ-01-175

drugId :
null

Target Vo:
Cyclin-dependent kinase 12

Target Vo Short Name :
CDK12

Moa_Name:
Cyclin-dependent kinase 12 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Dana-Farber Cancer Institute

Active Company_Name :
Dana-Farber Cancer Institute

Active Indication_Name:
Sarcoma, Ewing

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Caspase-6 p18 Rabbit mAb MedChemExpress
Zilovertamab vedotin Biological Activity
p38 Antibody: p38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 41 kDa, targeting to p38. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts